If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConvaTec Regulatory News (CTEC)

Share Price Information for ConvaTec (CTEC)

Share Price is delayed by 15 minutes
Get Live Data
212.60    -1.60 (-0.75%)
Bid:
212.40
Ask:
212.80
Spread: 0.40 (0.188%)
Market Cap: £4.16b
CTEC Live PriceLast checked at - London Stock Exchange

Intraday ConvaTec Share Chart

Director/PDMR Shareholding

12 Mar 2025 12:00

RNS Number : 3962A
Convatec Group PLC
12 March 2025
 

12 March 2025

Convatec Group Plc("Convatec" or "the Company")

Director/ PDMR Shareholding 

The Company has been notified of the following transactions in relation to Persons Discharging Managerial Responsibility ("PDMR") in respect of ordinary shares of 10 pence each in the Company ("Shares").

1. Grant of Awards under the Company's Long Term Incentive Plan ("LTIP")

 

On 11 March 2025, conditional awards were granted to Karim Bitar, Chief Executive Officer and Jonny Mason, Chief Financial Officer under the LTIP in the form of Performance Share Awards ("PSA"). These PSA are due to vest on the third anniversary of grant at nil cost, conditional on the following performance conditions: organic revenue growth, three-year compound annualised growth in adjusted Earnings per Share, and three-year Relative Total Shareholder Return rank vs constituents of S&P Global Healthcare Equipment & Services index; and subject to a two-year post vesting holding period.

Karim Bitar: 1,108,169

Jonny Mason: 501,448

2. Grant of Awards under the Company's Deferred Bonus Plan ("DBP")

On the same date, conditional awards were also granted to Karim Bitar and Jonny Mason, under the DBP in the form of Restricted Stock Units ("RSU"), which are due to vest on the third anniversary of grant at nil cost and are not subject to performance conditions:

Karim Bitar: 242,935

Jonny Mason: 131,914

The preceding three-day average share price, closing on 10 March 2025, of £2.6573 was used in determining each of the awards made under the LTIP and DBP.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1. Grant of Awards under the Company's Long Term Incentive Plan ("LTIP")

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Karim Bitar

2

Reason for the notification

a)

Position/Status

Chief Executive Officer and PDMR

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Convatec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary share of 10p each in Convatec Group Plc

 

 

Identification code

GB00BD3VFW73

b)

Nature of the transaction

Grant of PSA under the LTIP subject to performance conditions.

 

c)

Price(s) and volume(s)

Price(s)

 

Volume(s)

£0

1,108,169

d)

Aggregated information

- Aggregated volume 

- Price

 

N/A - single transaction

e)

Date of the transaction

2025-03-11

f)

Place of the transaction

Outside a trading venue

2. Grant of Awards under the Company's Long Term Incentive Plan ("LTIP")

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jonny Mason

2

Reason for the notification

a)

Position/Status

Chief Financial Officer and PDMR

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Convatec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary share of 10p each in Convatec Group Plc

 

 

Identification code

GB00BD3VFW73

b)

Nature of the transaction

Grant of PSA under the LTIP subject to performance conditions.

c)

Price(s) and volume(s)

Price(s)

 

Volume(s)

£0

501,448

d)

Aggregated information

- Aggregated volume 

- Price

 

N/A - single transaction

e)

Date of the transaction

2025-03-11

f)

Place of the transaction

Outside a trading venue

3. Grant of Awards under the Company's Deferred Bonus Plan ("DBP")

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Karim Bitar

2

Reason for the notification

a)

Position/Status

Chief Executive Officer and PDMR

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Convatec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary share of 10p each in Convatec Group Plc

 

 

Identification code

GB00BD3VFW73

b)

Nature of the transaction

 Grant of RSU under the DBP, subject to a time-based vesting period of three years.

c)

Price(s) and volume(s)

Price(s)

 

Volume(s)

£0

242,935

d)

Aggregated information

- Aggregated volume 

- Price

 

N/A - single transaction

e)

Date of the transaction

2025-03-11

f)

Place of the transaction

Outside a trading venue

4. Grant of Awards under the Company's Deferred Bonus Plan ("DBP")

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jonny Mason

2

Reason for the notification

a)

Position/Status

Chief Financial Officer and PDMR

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Convatec Group Plc

b)

LEI

213800LS272L4FIDOH92

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary share of 10p each in Convatec Group Plc

 

 

Identification code

GB00BD3VFW73

b)

Nature of the transaction

 Grant of RSU under the DBP, subject to a time-based vesting period of three years.

c)

Price(s) and volume(s)

Price(s)

 

Volume(s)

£0

131,914

d)

Aggregated information

- Aggregated volume 

- Price

 

N/A - single transaction

e)

Date of the transaction

2025-03-11

f)

Place of the transaction

Outside a trading venue

 

 

Enquiries

James Kerton Company Secretary Tel: +44 (7827) 036059 Email: cosec@convatec.com

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

Classification: 2.2 Information disclosed under article 19 of the Market Abuse Regulation

About Convatec

 

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than 10,000 colleagues, we provide our products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Convatec's revenues in 2024 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more please visit http://www.convatecgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLLVVIFLIE
Date   Source Headline
24th Jul 20187:00 amRNSUS FDA 510(k) Clearance for AQUACELT Ag Advantage
23rd Jul 20183:27 pmRNSHolding(s) in Company
23rd Jul 20189:39 amRNSHolding(s) in Company
6th Jul 20189:53 amRNSDirector Declaration
3rd Jul 20187:00 amRNSBoard Changes
6th Jun 20185:20 pmRNSHolding(s) in Company
6th Jun 20185:18 pmRNSHolding(s) in Company
1st Jun 20187:00 amRNSTotal Voting Rights
21st May 20181:03 pmRNSDirector/PDMR Shareholding
21st May 20181:02 pmRNSDirector/PDMR Shareholding
11th May 20183:27 pmRNSAGM Corrected Poll Result
11th May 20187:00 amRNSAGM Special Resolutions at NSM
10th May 20183:57 pmRNSAGM Result of Meeting
8th May 20183:12 pmRNSDirector/PDMR Shareholding
8th May 201810:55 amRNSHolding(s) in Company
4th May 20184:33 pmRNSHolding(s) in Company
4th May 201811:47 amRNSHolding(s) in Company
3rd May 201810:39 amRNSDirector Declaration
3rd May 20187:00 amRNSResult of placing in ConvaTec Group Plc
2nd May 20187:00 amRNSQ1 Trading Update
26th Apr 20187:00 amRNSScrip Dividend- total issued shares
12th Apr 201810:30 amRNSScrip Dividend - calculation price
15th Mar 201811:00 amRNSNotice of AGM
8th Mar 20183:35 pmRNSDirector/PDMR Shareholding
2nd Mar 20187:00 amRNSChanges within U.S. Home Distribution Group
26th Feb 201811:24 amRNS2017 Annual Report & Accounts
15th Feb 20187:00 amRNSFinal Results
7th Feb 201811:17 amRNSHolding(s) in Company
21st Dec 201710:33 amRNSHolding(s) in Company
13th Dec 201712:40 pmRNSHolding(s) in Company
12th Dec 201710:01 amRNSHolding(s) in Company
6th Dec 20171:54 pmRNSDirector/PDMR Shareholding
4th Dec 20173:15 pmRNSDirector/PDMR Shareholding
4th Dec 20172:00 pmRNSOrganisation Appointments
27th Nov 20173:19 pmRNSHolding(s) in Company
15th Nov 201712:08 pmRNSDirector Declaration
1st Nov 20173:12 pmRNSDirector/PDMR Shareholding
1st Nov 201712:00 pmRNSDirector Declaration
1st Nov 20177:00 amRNSTotal Voting Rights
27th Oct 201711:13 amRNSHolding(s) in Company
20th Oct 20174:01 pmRNSHolding(s) in Company
19th Oct 201710:15 amRNSHolding(s) in Company
19th Oct 20177:00 amRNSDirector/PDMR Shareholding
17th Oct 20173:35 pmRNSHolding(s) in Company
17th Oct 20173:24 pmRNSHolding(s) in Company
16th Oct 20177:00 amRNSFY2017 guidance and third quarter update
5th Oct 20177:00 amRNSScrip Dividend - total issued shares
19th Sep 20177:00 amRNSGentleCath Glide and me+ Launches in Europe
14th Sep 201711:16 amRNSDirector/PDMR Shareholding
14th Sep 201710:09 amRNSScrip Dividend - calculation price

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.